These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 9245560
1. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. Mizumoto M, Arii S, Furutani M, Nakamura T, Ishigami S, Monden K, Ishiguro S, Fujita S, Imamura M. J Surg Res; 1997 Jul 01; 70(2):124-33. PubMed ID: 9245560 [Abstract] [Full Text] [Related]
2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Niederberger M, Ginés P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW. Hepatology; 1996 Oct 01; 24(4):947-51. PubMed ID: 8855203 [Abstract] [Full Text] [Related]
3. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY. Hepatobiliary Pancreat Dis Int; 2006 Nov 01; 5(4):564-9. PubMed ID: 17085343 [Abstract] [Full Text] [Related]
5. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects]. Zhang J, Zhou H. Zhonghua Wai Ke Za Zhi; 1998 May 01; 36(5):317-9. PubMed ID: 11825400 [Abstract] [Full Text] [Related]
6. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Xu J, Cao H, Liu H, Wu ZY. Hepatobiliary Pancreat Dis Int; 2008 Oct 01; 7(5):503-8. PubMed ID: 18842497 [Abstract] [Full Text] [Related]
7. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats. Wang H, Chen XP, Qiu FZ. Hepatobiliary Pancreat Dis Int; 2003 Aug 01; 2(3):391-6. PubMed ID: 14599946 [Abstract] [Full Text] [Related]
9. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Morales-Ruiz M, Jiménez W, Pérez-Sala D, Ros J, Leivas A, Lamas S, Rivera F, Arroyo V. Hepatology; 1996 Dec 01; 24(6):1481-6. PubMed ID: 8938184 [Abstract] [Full Text] [Related]
10. Increased blood flow through the portal system in cirrhotic rats. Vorobioff J, Bredfeldt JE, Groszmann RJ. Gastroenterology; 1984 Nov 01; 87(5):1120-6. PubMed ID: 6479534 [Abstract] [Full Text] [Related]
14. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats]. Albornoz L, Bandi JC, de las Heras M, Mastai R. Medicina (B Aires); 2000 Nov 01; 60(4):477-81. PubMed ID: 11188955 [Abstract] [Full Text] [Related]
16. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. López-Talavera JC, Levitzki A, Martínez M, Gazit A, Esteban R, Guardia J. J Clin Invest; 1997 Aug 01; 100(3):664-70. PubMed ID: 9239414 [Abstract] [Full Text] [Related]
19. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Rockey DC, Weisiger RA. Hepatology; 1996 Jul 01; 24(1):233-40. PubMed ID: 8707268 [Abstract] [Full Text] [Related]
20. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance. Zhang ZQ, Qiu JF, Luo M, Sun YW, Zhao G, Chen W, Liu H, Wu ZY. J Gastroenterol Hepatol; 2008 Aug 01; 23(8 Pt 2):e487-93. PubMed ID: 18070013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]